In a small trial using oral sodium clodronate, a bisphosphonate like Zometa and Fosamax, it was shown to extended prostate cancer survival by 23 percent (23%). The survival benefit was seen only when the drug was used in combination with hormone therapy in men with metastatic disease. Many doctors have believed that bisphosphonates could have [...]
I cannot help it but every time I hear about someone who has died from cancer, it takes a toll on my spirit and knocks me down a notch. I hurt for the person, for their family and their friends. I also hurt deeply for myself, because I know that I too may not survive [...]
The following observation was made by Michael Lerner, Ph.D, winner of a MacArthur "genius" award and author of a book about cancer and complementary medicine : Choices in Healing: Integrating the Best of Conventional and Complementary Medicine (MIT Press, 1996). (Available at amazon.com.) "Even when a cure is not possible, healing always is. You see, [...]
Today’s New York Times has published another of its fantastic articles about cancer and coping with cancer. Today’s article, written by Jane Brody, discusses chemo brain. Until a short time ago, many doctors denied that it even existed, but today it is pretty much accepted as being real. One is said to suffer from chemo [...]
Many doctors believe that increased levels of C-reactive protein (CRP) is associated with adverse outcomes in men with castration-resistant prostate cancer (CRPC) treated with docetaxel. C-reactive protein is a protein found in the blood, the levels of which rise in response to inflammation in any part of the body. Traditionally measuring levels of c-reactive protein [...]